Data Characteristics for this Category
siRNA nucleic acid drug clinical trial data originates primarily from clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), pharmaceutical company internal R&D databases, and scientific literature (PubMed, Scopus). Data update frequencies vary; registry information typically updates after trials reach specific stages, while literature data follows journal publication cycles. Document structures are mainly semi-structured and unstructured, including study protocols, ethical approval documents, patient recruitment criteria, adverse event reports, and biomarker test results. Fields include target genes, siRNA sequence information, administration routes, dosages, subject genotypes, disease staging, and primary/secondary endpoints (e.g., gene expression levels, protein concentration, clinical symptom improvement). Units commonly include molar concentration (nM), dosage (mg/kg), time (weeks, months), and gene expression fold change.
Constraints Imposed by these Characteristics on "Deployment and Upgrade"
The semi-structured and unstructured nature of siRNA nucleic acid drug data requires robust text parsing capabilities during the knowledge base platform's data ingestion phase, especially for PDF-formatted study protocols and results reports. Frequent data updates, particularly from registries and literature, necessitate deploying scheduled synchronization mechanisms to avoid manual intervention. Specific fields like siRNA sequences and target genes demand high accuracy in entity recognition and relationship extraction, requiring configuration of specialized Named Entity Recognition (NER) models or rules. Clinical trial data volumes are typically large and contain sensitive information, requiring significant storage and computational resources, along with deployment environments that meet stringent data security and compliance standards. Complex biological and medical terminology, coupled with diverse units of measurement, also requires refined processing during vectorization and retrieval to ensure accurate semantic understanding.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Clinical trial reports often contain numerous charts and raw data, leading to large file sizes. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Complex PDF document parsing can be time-consuming; this prevents parsing timeouts. |
maxContext | 800–1200 characters | siRNA clinical trial context information is dense, requiring a longer context window for understanding. |
Chunk size | 500 characters | Balances contextual completeness with retrieval efficiency, preventing long segments from diluting key information. |
Recall count | Top 10 entries | Ensures retrieval of sufficient relevant clinical trial details and biological data. |
Similarity threshold | Calibrate based on actual measurements, suggested 0.75-0.85 range | Balances recall rate and accuracy; siRNA sequences and target information require high similarity matching. |
Three Common Mistakes
- Symptom: After system startup, the model list is empty, and conversations cannot be initiated. Reason:
OPENAI_BASE_URLorONEAPI_BASE_URLinconfig.jsonis configured incorrectly, preventing connection to the model service. - Symptom: Uploading a large PDF clinical trial report results in prolonged unresponsiveness or errors during file processing. Reason: The
UPLOAD_FILE_MAX_SIZEparameter is set too low, and the file exceeds the maximum upload limit allowed by the server. - Symptom: Retrieval results show incorrect matches or missing information for siRNA sequences or gene targets. Reason: During knowledge base construction, specific Named Entity Recognition rules or dictionaries for the siRNA domain were not configured, leading to critical information not being correctly extracted and vectorized.
How to Confirm Proper Configuration
- Upload a PDF clinical trial report containing siRNA sequences, target genes, and clinical endpoints. Verify that the file is successfully parsed and ingested, and that key field information is retrievable.
- Query the knowledge base about specific siRNA nucleic acid drug clinical trial data (e.g., "What were the primary endpoints for a certain siRNA drug in Phase II clinical trials?"). Verify the accuracy and completeness of the returned results.
- Check system logs to confirm that data synchronization tasks (e.g., from ClinicalTrials.gov) execute successfully at the preset frequency, without connection or parsing errors.
- Use different query methods (e.g., keywords, natural language questions) to test the system's understanding of siRNA-related terminology and biological concepts, and evaluate the relevance of recall results.
Note: The values given are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.